We recently discovered that upregulation of PSPC1 is associated with poor patient survival in cancers, including human hepatocellular carcinoma (HCC)4, a predominant form of liver cancer occurring mainly in developing countries. Here, PSPC1 is linked to hepatocellular carcinoma.